Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

May 06, 2019 | Daily News

The White House Office of National Drug Control Policy (ONDCP) said Friday (May 3) that its national drug policy strategy will reduce drug overdose deaths by 15% in five years, two months after a Government Accountability Office (GAO) report said the strategy lacked key information.

May 03, 2019 | Daily News

The House is scheduled to vote the week of May 6 on two minor drug-pricing bills that were part of a legislative package the House Energy & Commerce Committee passed last month.

May 03, 2019 | Daily News

House Energy & Commerce health subcommittee chair Rep. Anna Eshoo (D-CA) told aides Tuesday (April 30) that she is frustrated with the lack of communication between House Democratic leadership and other members regarding drug-pricing negotiations.

May 02, 2019 | Daily News

The Congressional Budget Office estimates that the HHS proposal to eliminate drug rebates paid to middlemen in Medicare and Medicaid managed care would increase federal spending $177 billion over a decade.

May 02, 2019 | Daily News

FDA plans to send a legislative proposal to Congress that would subject all dietary supplements to FDA’s food enforcement authorities, even if the product does not meet the technical definition of a dietary supplement.

May 02, 2019 | Daily News

Public Citizen has sued FDA for not acting on the group’s petition for the agency to add boxed warnings about impulse-control and compulsive behavior on labels of all dopamine agonist drugs approved in the United States and to establish a risk mitigation program for dopamine agonists.

May 01, 2019 | Daily News

The Congressional Budget Office said a single-payer health care system could lead drug makers to cut back research on new treatments and to shift their research focus to drugs that are significantly better than existing treatments.

May 01, 2019 | Daily News

The Senate Judiciary Committee will hold a hearing May 7 on drug makers' practices of gaming the patent system to extend their monopolies on prescription drugs.

May 01, 2019 | Daily News

President Donald Trump will meet soon with Democrats to discuss policies aimed at lowering drug costs, according to a White House press statement following a meeting on infrastructure that Trump held with democrats Tuesday (April 30) and Senate Minority Leader Chuck Schumer (D-NY).

May 01, 2019 | Daily News

The White House Council of Economic Advisers says falling out-of-pocket prices for opioids could explain between 31% and 83% of the growth in opioid overdose deaths between 2001 and 2010, and the council’s report tied that drop in costs to more government subsidization of the drugs through Medicare Part D and the entry of generics in the market.

May 01, 2019 | Daily News

Former FDA chief Scott Gottlieb recently expressed disappointment that he ran out of time to reform over-the-counter (OTC) drug regulations and spur use of technologies that could aid in more prescription-to-OTC switches.

April 30, 2019 | Daily News

Progressive Caucus Co-Chair Rep. Pramila Jayapal (D-WA) said Tuesday (April 30) that progressives told Ways & Means Chair Richard Neal (D-MA) and Energy & Commerce Chair Frank Pallone (D-NJ) that progressives would not support a Medicare price negotiation proposal with arbitration as a mechanism instead of direct negotiation.

April 30, 2019 | Daily News

The House Judiciary Committee on Tuesday (April 30) voted to send four drug-pricing and competition bills to the House floor, including pay-for-delay legislation, the CREATES Act and a bill that would allow the Federal Trade Commission (FTC) to crack down on brand drug makers’ use of sham citizen petitions to delay generic drug competition.

April 30, 2019 | Daily News

Conservative lawmakers, media, think tanks and pundits are split on the Trump administration’s proposed rule that would shift Medicare drug rebates to the point of sale.

April 29, 2019 | Daily News

The American Society for Radiation Oncology is urging Congress to revamp the prior authorization process, which oncologists surveyed by the group say delays cancer treatments.

April 29, 2019 | Daily News

Congressional Democrats and Republicans are considering delaying the Trump administration’s proposed ban of point-of-sale rebates and using savings from the delay to pay for other legislative priorities, sources said.

April 29, 2019 | Daily News

A day in advance of a meeting between progressives and key Democratic House committee chairmen to address a rift in the party’s drug-pricing priorities, a coalition of progressive consumer advocates, unions and think tanks did not take sides in the internal conflict over which enforcement mechanism to include in legislation allowing Medicare to negotiate drug prices with manufacturers.

April 29, 2019 | Daily News

The House Judiciary Committee will mark up four bills on Tuesday (April 30) that would give the Federal Trade Commission more power to crack down on abuses by brand and generic drug makers that lead to higher prescription drug prices, including the CREATES Act and pay-for-delay legislation.

April 26, 2019 | Daily News

Billionaire couple Laura and John Arnold have changed up their political spending game to strengthen their position as a counterforce to pharma’s deep-pocketed efforts to kill state bills to lower drug prices.

April 26, 2019 | Daily News

Advocates for HIV patients are scheduled to meet May 9 with White House budget officials to argue against a CMS proposal that would let insurers restrict coverage of drugs in six protected classes in Medicare Part D.

Pages